SapnaSyngalMDMPH
Gastroenterology • Boston, MADirector of Research, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute -- Co-Leader, Cancer Risk, Prevention, and Early Detection Program, Dana-Farber/Harvard Cancer Center -- Professor of Medicine, Harvard Medical School,
Dr. Syngal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue, Dana-Farber Cancer Institute, Division of Cancer Genetics and Prevention
75 Francis St, Brigham and Women's Hospital, Division Of Gastroenterology
Boston, MA 02115Phone+1 617-632-6164- Is this information wrong?
Education & Training
Brigham and Women's HospitalFellowship, Gastroenterology, 1993 - 1996
Harvard School of Public HealthMPH, Epidemiology, Biostatistics, 1993 - 1996- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
McGill University Faculty of MedicineClass of 1990
Certifications & Licensure
MA State Medical License 1992 - 2025
Awards, Honors, & Recognition
- Association of American Physicians 2018-2019
- Elected Member The American Society for Clinical Investigation, 2009
- Super Doctor SuperDoctors.com
Clinical Trials
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) Start of enrollment: 2013 Oct 01
- The Cancer of the Pancreas Screening-5 CAPS5)Study Start of enrollment: 2014 Jan 06
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer Start of enrollment: 2023 Apr 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsA Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pa...Nicolette J Rodriguez, C Sloane Furniss, Matthew B Yurgelun, Chinedu Ukaegbu, Pamela E Constantinou, Ileana Fortes, Alyson Caruso, Alison N Schwartz, Jill E Stopfer, M...> ;Gastroenterology. 2024 May 1
- PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.Renata L Sandoval, Miki Horiguchi, Chinedu Ukaegbu, C Sloane Furniss, Hajime Uno, Sapna Syngal, Matthew B Yurgelun> ;Familial Cancer. 2023 Oct 1
- 24 citationsYoung-onset colorectal cancer.Manon C W Spaander, Ann G Zauber, Sapna Syngal, Martin J Blaser, Joseph J Sung, Y Nancy You, Ernst J Kuipers> ;Nature Reviews. Disease Primers. 2023 Apr 27
- Join now to see all
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Press Mentions
Eliminating Racial Barriers in Genetic Testing: Dana-Farber Receives Innovative Pancreatic Cancer Research GrantsAugust 3rd, 2022- Let’s Talk About: Inequities in Access to Genetic TestingFebruary 24th, 2022
GENERATE Study Aims to Improve Genetic Testing and Prevention for Pancreatic CancerJune 24th, 2019- Join now to see all
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
